Skip to main content

Published locations for Mogamulizumab is ‘valuable’ option for CTCL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Mogamulizumab is ‘valuable’ option for CTCL

User login

  • Reset your password
  • /content/mogamulizumab-valuable-option-ctcl
  • /hematology-oncology/article/185146/lymphoma-plasma-cell-disorders/mogamulizumab-valuable-option-ctcl
  • /hematologytimes/article/185146/lymphoma-plasma-cell-disorders/mogamulizumab-valuable-option-ctcl